New Launch26 Sept 2025, 05:37 pm
SMS Lifesciences India Ltd Completes Successful ANVISA Inspection at Hyderabad Facility
AI Summary
SMS Lifesciences India Ltd, now known as Haleos Labs Limited, has successfully completed an inspection by the Brazilian Health Authority (ANVISA) at its API manufacturing facility in Hyderabad. The inspection took place from September 22, 2025, to September 26, 2025, and its completion reaffirms the company's compliance with international quality standards. This successful inspection paves the way for the company's entry into Brazil, the largest pharmaceutical market in South America.
Key Highlights
- SMS Lifesciences India Ltd's Hyderabad facility inspected by ANVISA
- Inspection took place from September 22, 2025, to September 26, 2025
- Company's compliance with international quality standards reaffirmed
- Paves the way for entry into Brazil, the largest pharmaceutical market in South America
- Company's name changed to Haleos Labs Limited